T. Matsunaga et al., IMPAIRMENT OF CORONARY BLOOD-FLOW REGULATION BY ENDOTHELIUM-DERIVED NITRIC-OXIDE IN DOGS WITH ALLOXAN-INDUCED DIABETES, Journal of cardiovascular pharmacology, 28(1), 1996, pp. 60-67
Diabetes mellitus is a major cause of ischemic coronary artery disease
. Endothelial dysfunction is implicated in the pathogenesis of diabeti
c vascular disease. To examine coronary blood flow (CBF) regulation wi
th endothelium-derived nitric oxide (EDNO) in the diabetic state, we c
ompared the effects of both acetylcholine (ACh) and adenosine (Ado) on
left circumflex coronary artery (LCX) blood flow in 12 vehicle-treate
d and 21 dogs made diabetic with alloxan anesthetized with pentobarbit
al. All dogs were pretreated with aspirin to inhibit endogenous prosta
glandins. None of the hemodynamic parameters were significantly differ
ent in the two groups. The percent change in coronary vascular resista
nce (CVR) after ACh (100 ng/kg) infusion was significantly attenuated
in diabetic dogs (-56.5 +/- 1.4%) as compared with vehicle-treated dog
s (-64.5 +/- 1.2%) (p < 0.01) whereas the effect of Ado (1 mu g/kg) wa
s not different between the two groups (-71.1 +/- 1.5% in vehicle, -67
.0 +/- 1.3% in diabetes). After infusion of incremental doses of N-G-n
itro-L-arginine methyl ester (L-NAME) 10-(5)-10(-3)M, the effect of AC
h was progressively inhibited in both groups and was different no long
er between the two groups after the maximal dose. L-Arginine (r-ARG),
but not D-ARG, significantly restored the effect of ACh in diabetic do
gs but did not affect vehicle-treated dogs, The effect of Ado did not
change after L- and D-ARG administration. Cu, Zn-superoxide dismutase
(Cu, Zn-SOD) had no effect on any of the effects of ACh and Ado in dia
betic dogs, Regulation of CBF with EDNO is impaired in dogs with allox
an-induced diabetes, and this impairment is partially restored by L-AR
G.